At my facility, we had three incidences (three different patients) where Rocuronium was not paralyzing patients as intended (i.e. anesthesia has had to use twice the dose of Rocuronium from manufacturer below as opposed to the standard dose from other manufacturer).

I have already submitted a case with the manufacturer, and in the interim, we have sequestered the lot and replaced with another manufacturer.

Manufacturer: Piramal Critical Care
Lot: 24410013

Just wanted to see if any one else has received similar feedback from using this manufacturer?

Hello Everyone,

Our anesthesiologists reported that the rocuronium was not effective when used at appropriate doses in three different patients, requiring a second dose. We typically buy rocuronium by auromedics. Has anyone heard of any issues using this manifacturer at your institutions?

Thank you,

Viktoriya Fridman, Pharm.D.
Medication Safety Specialist
Ocean University Medical Center
Brick, NJ

We recently had a request for rocuronium to be used in the Allergy clinic for patient sensitivity testing. As I found out, there is primary literature that speaks to allergy testing of NMBs when a patient has anaphylaxis to one of these agents since there is cross-reactivity. I prefer to have pharmacy own this process, to minimize the risk of a NMB used in clinic setting, but would like to hear how others are handling this type of request.